Literature DB >> 17555646

Formation of scopolamine from N-butyl-scopolammonium bromide in cigarettes.

Martine Frascht1, Serge Schneider, Marc Schuman, Robert Wennig.   

Abstract

Scopolamine (hyoscine) is a naturally occurring alkaloid found in solonacea, the so-called "night shade" plants. Therapeutic applications of scopolamine are in ophthalmology to cause mydriasis and for the prevention of motion sickness, among others. It is known to induce hallucinogenic effects at a high dose. The N-butyl bromide derivative of scopolamine, available commercially as Buscopan, is commonly used as an antispasmotic. The possibility of forming scopolamine from N-butyl-scopolammonium bromide when burning cigarettes fortified with Buscopan was investigated based on a record of a prison inmate who claimed to experience hallucinations after smoking Buscopan. Liquid chromatography-tandem mass spectrometry in electrospray ionization mode was used to monitor the formation of scopolamine. Various series of eight cigarettes spiked with 10 mg of N-butyl-scopolammonium bromide with and without filters and in different smoking modes were investigated. The smoke of the burning cigarettes, the ashes, and the filter were analyzed for the presence of scopolamine. Scopolamine was detected in all cases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17555646     DOI: 10.1093/jat/31.4.220

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  2 in total

1.  Abuse of the over-the-counter antispasmodic butylscopolamine for the home synthesis of psychoactive scopolamine.

Authors:  Sebastian Kummer; Annette Rickert; Thomas Daldrup; Ertan Mayatepek
Journal:  Eur J Pediatr       Date:  2015-12-22       Impact factor: 3.183

2.  Scopolamine fatal outcome in an inmate after buscopan® smoking.

Authors:  Sabina Strano-Rossi; Serena Mestria; Giorgio Bolino; Matteo Polacco; Simone Grassi; Antonio Oliva
Journal:  Int J Legal Med       Date:  2021-04-23       Impact factor: 2.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.